Los Angeles Capital Management LLC Ironwood Pharmaceuticals Inc Transaction History
Los Angeles Capital Management LLC
- $28.5 Billion
- Q3 2025
A detailed history of Los Angeles Capital Management LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 1,130,052 shares of IRWD stock, worth $3.55 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,130,052
Previous 1,211,155
6.7%
Holding current value
$3.55 Million
Previous $872,000
69.72%
% of portfolio
0.01%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding IRWD
# of Institutions
187Shares Held
160MCall Options Held
11.2MPut Options Held
11.7K-
Black Rock Inc. New York, NY22.9MShares$71.8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$50.7 Million0.32% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.1MShares$50.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$50 Million13.13% of portfolio
-
Bank Of America Corp Charlotte, NC11.7MShares$36.7 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $481M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...